Journal profile · Medicine-Dermatology
JEADV Clinical Practice
ISSN 2768-6566 · Wiley · United Kingdom
JEADV Clinical Practice: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 0.7 (journal website); fully open access; APC about USD 2,540; median 125 days to acceptance (104 articles, last 24 months); acceptance rate 54% (journal website); 286 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JEADV Clinical Practice is published by Wiley and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases and Psoriasis: Treatment and Pathogenesis, together about 27.5% of its articles. Its main subfields are Dermatology and Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
The JEADV Clinical Practice (JEACP) is an open access (OA) peer-reviewed publication of the European Academy of Dermatology and Venereology (EADV) and a companion title to the well-established Journal of the European Academy of Dermatology and Venereology (JEADV). The aim of the JEACP is to cater the ever-growing need of the dermatology and venereology community for open access to scientific publications as well as for more clinically-oriented content worldwide. This journal features cutting-edge clinical and educational content, providing practical, hands-on information directly relevant to managing the dermatologist’s and venereologist’s office and the acquisition of state-of-the-art clinical and surgical skills. The JEACP covers all aspects of dermatology, and our target audience includes clinical, surgical and aesthetic dermatologists and venereologists in hospitals or in private practice, as well as researchers, nurses, patients and their caregivers. The JEACP strives to become a go-to OA resource for everyone keen on staying up-to-date with the management of skin and/or venereal diseases. Our aim is to make the newest scientific findings rapidly available to the community and to this end, every paper undergoes rigorous and fast peer-review. The journal publishes various types of research papers, including pilot and proof of concept studies, study protocols, investigations of innovative technologies in addition to short reports, original and review articles, including multidisciplinary periodical reviews and others. Particular attention will be given to articles that feature case reports with outstanding teaching value and innovative techniques and procedures. The JEACP is an innovative journal that explores the unlimited possibilities a fully-digital publication has to offer, hence authors are encouraged to include high-quality images, as well as digital media, such as high-quality videos, whenever possible. The JEACP is a patient-centred journal – in the heart of our mission is the improvement of quality of care for people living with skin and/or venereal diseases. In our Patient Page Section, the journal provides reliable health information and features testimonials, advocacy and thought leadership pieces concerning patient-centred care. Authors are encouraged to include a lay language summary of their research whenever possible. We also invite manuscripts written by nurses, co-created by clinicians and expert patients and patient organisations. Th
From the journal's Aims & Scope
Research area (LetPub): Medicine-Dermatology
Editor-in-chief Antonio TorreloPublisher website
Editorial board by country: 4 in mainland China (about 5%); most named Italy 15, Spain 10, Switzerland 8, France 5, Mainland China 4 (84 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatology and Skin DiseasesMedicine11.6%
- Autoimmune Bullous Skin DiseasesMedicine8.1%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology7.8%
- Cutaneous lymphoproliferative disorders researchMedicine6.3%
- Cutaneous Melanoma Detection and ManagementMedicine5.6%
- Nonmelanoma Skin Cancer StudiesMedicine4.4%
- Hidradenitis Suppurativa and TreatmentsMedicine4.4%
- Nail Diseases and TreatmentsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.7Publisher website ·
- Impact factor (publisher) 2025
- 0.7Publisher website ·
- CiteScore 2026-06
- 1LetPub ·
- CiteScore (publisher)
- 1Publisher website ·
- CiteScore (publisher) 2025
- 1Publisher website ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 25OpenAlex ·
- 2-year mean citedness
- 0.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 177LetPub ·
- Articles per year (publisher) 2025
- 271Publisher website ·
- Downloads per year (publisher) 2025
- 398,333Publisher website ·
Articles by year OpenAlex count · 1,077 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 189 | 189 | 24 |
| 2025 | 286 | 286 | 141 |
| 2024 | 262 | 262 | 433 |
| 2023 | 244 | 244 | 347 |
| 2022 | 95 | 95 | 338 |
| 2021 | 1 | 1 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
125 daysMedian, submission to acceptance · P25–P75 87 days – 172 days
- Acceptance to online
- median 14 days (106 articles)
- Submission to online
- median 144 days
- Sample
- 104 articles with submission and acceptance dates (526 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Acceptance rate (publisher)
- 54%Publisher website ·
- Acceptance rate (publisher) 2025
- 54%Publisher website ·
- Submission to first decision
- 36 daysPublisher website ·
- Submission to first decision 2025
- 36 daysPublisher website ·
- Submission to acceptance 2025
- 113 daysPublisher website ·
- Acceptance to publication 2025
- 17 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,540 / GBP 1,900 / EUR 2,290 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,310 / EUR 2,080 / GBP 1,730 | — | — | |
| LetPub | USD 2,200 / GBP 1,650 / EUR 1,980 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≥ 2
- Manuscript length
- ≤ 3,500 words
- Highlights
- Required
- Cover letter
- Required
- Not considered
- RCTs without CONSORT checklist and flow diagram
Article types accepted7, with length limits
- case reportFor Case Reports, Authors are encouraged to provide manuscript previews. Case Report Previews offer a concise pictorial summary of the main findings of the arti…abstract ≤ 80 words
- meta-analysisJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
- narrative reviewJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
- original articleJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
- reviewJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
- review articleJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
- systematic reviewJEADV Clinical Practice (JEACP) welcomes the following types of submissions: Article type Aim of the article Subcategory Instructions and Requirements Original …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- Authorship Authorship
The Journal's authorship criteria are adapted from those of the ICMJE and all persons designated as Authors should qualify for authorship as delineated below. Each Author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more Authors should take responsibility for the integrity of the work as a whole, from inception to p…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
JEACP requires Authors to disclose any financial, personal, or professional relationships that might be perceived as influencing their objectivity, as these are considered potential conflicts of interest. Examples include, but are not limited to, stock ownership, board or advisory roles, consultancy, or speaker’s fees. The presence of a conflict does not preclude publication. Authors must complete…
Source ↗Publisher website ·- Data availability JEACP Data Sharing Policy
This journal expects and peer-reviews data sharing. The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, Authors are required to include in their data availability statement a link to…
Source ↗Publisher website ·- Publication ethics Ethical Approval
JEACP follows COPE guidance on ethical oversight and ICMJE recommendations relating to research involving human participants and animals, including the protection of participant privacy and informed consent. All research submitted to the journal must be conducted and reported in line with these principles. All research involving human participants must comply with the ethical standards of the rele…
Source ↗Publisher website ·- License & copyright Copyright
If your article is accepted, the Author identified as the formal Corresponding Author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all Authors on the paper.
Source ↗Publisher website ·- Open access 4. Open Access
All articles published by JEACP are fully Open Access. This means that upon publication they are immediately freely available online for all to read, download, and share. To provide open access, this journal has an Article Publication Charge (APC) which needs to be met by the Authors or their research funders. For more information on this journal’s APCs, please see the Open Access page. Learn more…
Source ↗Publisher website ·- Peer review 3. Peer Review Model
JEACP operates a single-anonymized peer review model for applicable article types, in which reviewers remain anonymous to Authors. All submissions undergo initial editorial assessment. Manuscripts may be returned to Authors prior to peer review if they fall outside the Journal’s scope or do not meet minimum standards of scientific quality, clinical relevance, ethical compliance, or submission comp…
Source ↗Publisher website ·- Plagiarism Plagiarism and misconduct
JEACP adheres strictly to COPE’s Code of Conduct for Journal Editors. This means that if the Editors suspect research misconduct, the article in question will be held in abeyance until the matter is resolved. The Editors will contact the Authors and any appropriate third party to ascertain whether the grounds for investigation are justified. If a research paper that has been published in JEACP is …
Source ↗Publisher website ·- Preprints Preprint policy
JEACP accepts submissions previously posted on recognised preprint servers (e.g. bioRxiv, medRxiv, SSRN). Authors should declare any preprint posting in the cover letter at the time of submission. Upon acceptance, Authors are required to update any pre-publication versions with a link to the final published article. As JEACP is a fully open access journal, Authors may also post the final published…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2768-6566
- Latest issue on the website
- Volume 5, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JEADV Clinical Practice
What CAS zone is JEADV Clinical Practice in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JEADV Clinical Practice?
The journal's website gives an impact factor of 0.7 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1, h-index 13.
How long does peer review take at JEADV Clinical Practice?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 87–172 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 54% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JEADV Clinical Practice?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≥ 2; Manuscript length: ≤ 3,500 words; Highlights: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JEADV Clinical Practice based?
Of the 84 board members whose country the journal's board page names, 4 (about 5%) are in mainland China; the countries named most often are Italy (15), Spain (10) and Switzerland (8). Counted from the institutions listed on the board page; for reference only.
Which databases index JEADV Clinical Practice?
According to LetPub and DOAJ records, JEADV Clinical Practice is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.
Is JEADV Clinical Practice open access, and what is the APC?
JEADV Clinical Practice is a fully open-access journal. APC about USD 2,540.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .